|Bid||120.81 x 800|
|Ask||120.95 x 900|
|Day's range||120.21 - 123.41|
|52-week range||120.21 - 180.36|
|Beta (5Y monthly)||1.21|
|PE ratio (TTM)||30.91|
|Earnings date||03 Feb 2022 - 07 Feb 2022|
|Forward dividend & yield||0.96 (0.78%)|
|Ex-dividend date||27 Dec 2021|
|1y target est||169.50|
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today announced early results of the previously announced tender offers (collectively, the "Tender Offers" and each a "Tender Offer") to purchase for cash (i) any and all of its 3.700% Senior Notes due 2023 (the "Any and All Notes") and (ii) up to the aggregate purchase price set forth below (excluding accrued and unpaid interest up to, but not including, the applicable Settlement Date (as defined below) and excluding fees and expe
With its stock down 14% over the past month, it is easy to disregard Zimmer Biomet Holdings (NYSE:ZBH). It seems that...
The third quarter brings greater COVID-related pressure than expected for Zimmer Biomet (ZBH).